"We’re dedicated to helping people with rheumatoid arthritis, osteoporosis, autoimmune diseases and other musculoskeletal conditions. We use the latest technologies and treatments to restore health and enhance well-being."

During the past decade, Arthritis Center of Nebraska conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis Center of Nebraska" #1 sponsor was "Human Genome Sciences Inc." with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Merrimack Pharmaceuticals" with 2 trials sponsored, "Coherus Biosciences, Inc." with 1 trials sponsored and "Endo Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Center of Nebraska" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Center of Nebraska" are "Rheumatoid Arthritis" (6 trials), "Arthritis, Rheumatoid" (1 trials), "Autoimmune Disorder" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Osteoarthritis of the Knee" (1 trials). Many other conditions were trialed in "Arthritis Center of Nebraska" in a lesser frequency.

Most popular intervention types in "Arthritis Center of Nebraska" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Belimumab 1 mg/kg" (2 trials), "Belimumab 10 mg/kg" (2 trials), "Belimumab 4 mg/kg" (2 trials), "MM-093" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Center of Nebraska" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Arthritis Center of Nebraska". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Arthritis Center of Nebraska, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Center of Nebraska, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".